HSD17B13 Antibody / SCDR9 Antibody (RQ8719)

HSD17B13 Antibody Staining of Human Liver Cancer IHC. Immunohistochemistry of FFPE human liver cancer tissue using HSD17B13 Antibody. HIER was performed by boiling tissue sections in pH 8 EDTA for 20 min followed by cooling before staining. Strong granular brown cytoplasmic immunoreactivity is visible throughout numerous tumor cells, demonstrating detection of SCDR9 in the tested liver cancer tissue.

HSD17B13 Antibody Staining of Human Pancreatic Ductal Adenocarcinoma IHC. Immunohistochemistry of FFPE human pancreatic ductal adenocarcinoma tissue using HSD17B13 Antibody. HIER was performed by boiling tissue sections in pH 8 EDTA for 20 min followed by cooling before staining. Brown cytoplasmic immunoreactivity is visible within malignant glandular epithelial cells, with comparatively less staining in the surrounding stromal tissue, demonstrating detection of SCDR9 in the tested tumor specimen.

HSD17B13 Antibody Staining of Human Testicular Seminoma IHC. Immunohistochemistry of FFPE human testicular seminoma tissue using HSD17B13 Antibody. HIER was performed by boiling tissue sections in pH 8 EDTA for 20 min followed by cooling before staining. Brown cytoplasmic immunoreactivity is visible in a population of tumor cells distributed throughout the tissue, demonstrating detection of SCDR9 in the tested seminoma specimen.

HSD17B13 Antibody Detection in Human, Rat and Mouse Samples WB. Western blot analysis using HSD17B13 Antibody with lysates from 1) human HCCP, 2) rat liver, 3) rat RH-35 cells and 4) mouse liver. HSD17B13 has predicted molecular weights of approximately 34 kDa for isoform A and 30 kDa for isoform B. Prominent bands are detected at approximately 30-32 kDa across all four samples, consistent with the expected size range of HSD17B13 and demonstrating cross-species detection of SCDR9 under the tested conditions.

HSD17B13 Antibody Detection in HepG2 Human Liver Cancer Cells FACS. Flow cytometry analysis of fixed and permeabilized human HepG2 hepatocellular carcinoma cells using HSD17B13 Antibody at 1 ug/million cells following blocking with goat sera. The antibody-stained population (blue) shows a strong rightward fluorescence shift relative to the isotype control (green) and cells-alone control (red), demonstrating intracellular detection of SCDR9 in HepG2 cells under the tested conditions.